Shenglin Mei

8.1k total citations · 4 hit papers
65 papers, 4.7k citations indexed

About

Shenglin Mei is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shenglin Mei has authored 65 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Immunology and 13 papers in Oncology. Recurrent topics in Shenglin Mei's work include Bone Tissue Engineering Materials (10 papers), Genomics and Chromatin Dynamics (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Shenglin Mei is often cited by papers focused on Bone Tissue Engineering Materials (10 papers), Genomics and Chromatin Dynamics (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Shenglin Mei collaborates with scholars based in United States, China and Sweden. Shenglin Mei's co-authors include Paul K. Chu, Lingzhou Zhao, Myles Brown, Qian Qin, X. Shirley Liu, Clifford A. Meyer, Qiu Wu, Zhifen Wu, Rongbin Zheng and Hanfei Sun and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Shenglin Mei

57 papers receiving 4.7k citations

Hit Papers

Cistrome Data Browser: expanded datasets and new tools fo... 2017 2026 2020 2023 2018 2017 2022 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis
    2018 524 citations Rongbin Zheng, Changxin Wan et al. profile →
  2. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism
    2017 517 citations Youdong Pan, Shenglin Mei et al. profile →
  3. Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis
    2022 233 citations Wanyan Deng, Yang Bai et al. profile →
  4. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
    2023 126 citations Taghreed Hirz, Shenglin Mei et al. profile →

Peers

Shenglin Mei
Zhaocai Zhou China
Lesley G. Ellies United States
John M. Whitelock Australia
Chrysostomi Gialeli Greece
Wilhelm K. Aicher Germany
Zamri Radzi Malaysia
Spyros S. Skandalis Greece
Bin Wang China
Wendy F. Liu United States
Susan L. Bellis United States
Zhaocai Zhou China
Shenglin Mei
Citations per year, relative to Shenglin Mei Shenglin Mei (= 1×) peers Zhaocai Zhou

Countries citing papers authored by Shenglin Mei

Since Specialization
Citations

This map shows the geographic impact of Shenglin Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglin Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglin Mei more than expected).

Fields of papers citing papers by Shenglin Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglin Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglin Mei. The network helps show where Shenglin Mei may publish in the future.

Co-authorship network of co-authors of Shenglin Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglin Mei. A scholar is included among the top collaborators of Shenglin Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglin Mei. Shenglin Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Hirak, Jörg Otte, Thale Kristin Olsen, et al.. (2025). Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State. Cancer Research. 85(6). 1015–1034. 2 indexed citations
2.
3.
Mei, Shenglin, Bronte Manouk Verhoeven, Ting Zhao, et al.. (2024). Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature. JCI Insight. 9(6). 8 indexed citations
4.
He, Lingli, Ting Zhao, Wei Zhong Leong, et al.. (2024). AML Stem Cell Clearance By Inhibiting Selenoprotein Biosynthesis That Causes Cgas-Sting Activation and Ferroptosis. Blood. 144(Supplement 1). 1354–1354. 1 indexed citations
5.
Verhoeven, Bronte Manouk, Thale Kristin Olsen, Shenglin Mei, et al.. (2024). Genomic tumor evolution dictates human medulloblastoma progression. Neuro-Oncology Advances. 6(1). vdae172–vdae172. 1 indexed citations
6.
Zhao, Enfeng, et al.. (2024). Abstract LB342: Potent Anti-Tumor Activity Demonstrated by Anti-AXL CAR T Cell Therapy and AXL-ADC in Lung Cancer and Breast Cancer Models. Cancer Research. 84(7_Supplement). LB342–LB342. 1 indexed citations
7.
Zhang, Manqi, et al.. (2023). Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer. Cancers. 15(22). 5418–5418. 1 indexed citations
8.
Chaudagar, Kiranj, Shenglin Mei, Taghreed Hirz, et al.. (2023). 1537 Androgen blockade primes NLRP3 inflammasome in macrophages to induce tumor cell phagocytosis. SHILAP Revista de lepidopterología. A1760–A1762. 1 indexed citations
9.
Buonomo, Erica L., Shenglin Mei, Michael J. Peluso, et al.. (2022). Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages. Journal of Hepatology. 76(5). 1127–1137. 23 indexed citations
10.
Xu, Yuqiu, Mei Feng, Dexiang Zhu, et al.. (2022). Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers. Cell Reports. 40(9). 111295–111295. 44 indexed citations
11.
Haase, Christa, Karin Gustafsson, Shenglin Mei, et al.. (2022). Image-seq: spatially resolved single-cell sequencing guided by in situ and in vivo imaging. Nature Methods. 19(12). 1622–1633. 23 indexed citations
12.
Zheng, Zengzhang, Wanyan Deng, Yang Bai, et al.. (2021). The lysosomal Rag-Ragulator complex licenses RIPK1– and caspase-8–mediated pyroptosis by Yersinia. Science. 372(6549). 147 indexed citations
13.
Feng, Mei, Yan Zhou, Shenglin Mei, et al.. (2021). BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer. Signal Transduction and Targeted Therapy. 6(1). 313–313. 28 indexed citations
14.
Kfoury, Youmna, Ninib Baryawno, Nicolas Sévère, et al.. (2021). Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell. 39(11). 1464–1478.e8. 148 indexed citations
15.
Qin, Qian, Jing‐Yu Fan, Rongbin Zheng, et al.. (2020). Lisa: inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data. Genome biology. 21(1). 168 indexed citations
16.
Zhao, Linjie, Shuang Huang, Shenglin Mei, et al.. (2018). Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis. Proceedings of the National Academy of Sciences. 115(16). E3673–E3681. 60 indexed citations
17.
Mei, Shenglin, Clifford A. Meyer, Rongbin Zheng, et al.. (2017). Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer. Cancer Research. 77(21). e19–e22. 106 indexed citations
18.
Wang, Su, Chongzhi Zang, Tengfei Xiao, et al.. (2016). Modeling cis-regulation with a compendium of genome-wide histone H3K27ac profiles. Genome Research. 26(10). 1417–1429. 60 indexed citations
19.
Yoshida, Taku, Jee Hyun Kim, Kristopher Carver, et al.. (2015). CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer. Cancer Research. 75(7). 1516–1526. 84 indexed citations
20.
Mei, Shenglin, Huaiyu Wang, Wei Wang, et al.. (2014). Antibacterial effects and biocompatibility of titanium surfaces with graded silver incorporation in titania nanotubes. Biomaterials. 35(14). 4255–4265. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaocai Zhou Breakdown of academic impact, for papers by Lesley G. Ellies Breakdown of academic impact, for papers by John M. Whitelock Breakdown of academic impact, for papers by Chrysostomi Gialeli Breakdown of academic impact, for papers by Wilhelm K. Aicher Breakdown of academic impact, for papers by Zamri Radzi Breakdown of academic impact, for papers by Spyros S. Skandalis Breakdown of academic impact, for papers by Bin Wang Breakdown of academic impact, for papers by Wendy F. Liu Breakdown of academic impact, for papers by Susan L. Bellis
Rankless by CCL
2026